Published: Dec 2017
ACE Report #10021
Ace Report Cover Spine

E. coli-derived rhBMP-2 offers similar fusion success to AIBG in posterolateral lumbar fusion

Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

Efficacy of Escherichia coli-derived recombinant human bone morphogenetic protein-2 in posterolateral lumbar fusion: an open, active-controlled, randomized, multicenter trial

Spine J. 2017 Dec;17(12):1866-1874

Contributing Authors: JH Lee HJ Kim KH Koo CK Lee KB Lee H Kim KS Suk JJ Yang JH Cho CJ Hwang J Han JS Yeom BS Chang WD Nam

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.


Please Login or Join to leave comments.